GRACEcast Cancer 101 Video

Dr. Larry Einhorn, Distinguished Professor of Medicine at Indiana Univ and former ASCO president, discusses the trend of patients consulting Dr.Google - finding information of varied quality on the internet.

Dr. Larry Einhorn, Distinguished Professor of Medicine at Indiana Univ and former ASCO president, gives his view on whether a supercomputer such as Watson will be able to use complex algorithms to improve cancer care.

Dr. Larry Einhorn, Distinguished Professor of Medicine at Indiana Univ and former ASCO president, gives his view on more widespread availability of new mutation tests.

Dr. Larry Einhorn, Distinguished Professor of Medicine at Indiana Univ and former ASCO president, on what he sees as the most significant changes in cancer care in the last decade or two.

Dr. Larry Einhorn, Distinguished Professor of Medicine at Indiana Univ and former ASCO president, discusses leading challenges he sees for effective delivery of the best cancer care over the next decade.

Dr. Larry Einhorn, Indiana University, expresses his concerns about the cost of developing cancer drugs and the challenge of paying for extremely expensive cancer treatments that are given in anticipation of modest clinical benefits.

Dr. Larry Einhorn, Indiana University, explains why some cancers such as testicular cancer can have such a high cure rate while most others are far more challenging to cure with our current systemic therapies, offering an optimistic view of the future.

Dr. Ramalingam answers questions on the changing landscape of cancer clinical trials and how new studies are being designed in the new era of molecular oncology.

Dr. Ramalingam, from Winship Cancer Center at Emory University in Atlanta, dispels several myths that have created barriers to patient participation in clinical trials and highlights the rights of a patient interested in enrolling on a study.

Dr. Ramalingam, from Winship Cancer Center at Emory University in Atlanta, explains the process of developing a clinical trial, from identifying the most important questions to navigating it through the design and implementation process and enrolling patients.

Dr. Ramalingam, from Winship Cancer Center at Emory University in Atlanta, reviews what constitutes a clinical trial and discusses the phases of studies in the process of clinical research.

Dr. Jack West thanks the GRACE community for their generous support in our recent Annual Appeal and offers his wishes for a happy and healthy 2013.

Dr. Jack West wishes the cancer community a happy holiday season from GRACE.

Dr. Jack West describes a potentially efficient way to improve delivery of increasingly specialized care to broad geographic areas by collaboration of healthcare network teams using telemedicine solutions currently available.

Dr. Jack West discusses the pros and cons of repeat biopsies of tumors in the setting of "acquired resistance" to targeted therapies, with a specific consideration of whether this should be considered a standard of care.

Dr. Jack West reviews the limitations of artificial intelligence applied to clinical decision-making in complex cases in oncology, and why Dr. Watson won't necessarily become the perfect oncologist.

Dr. Dara Aisner, Pathologist at the University of Colorado, describes emerging technological changes that will advance how molecular marker testing is done, to make it faster and more complete over time.

Dr. Dara Aisner, Pathologist at the University of Colorado, reviews several practical challenges about having enough tissue for molecular testing, as well as the accuracy of the tests in different labs.

Dr. Dara Aisner, Pathologist at the University of Colorado, defines the field of pathology and molecular marker testing for cancer.

Dr. H. Jack West describes the new format of presenting cancer information in brief, more casual video-based format.

The GRACEcast feeds on iTunes are moving!

Dr. Kristin Manning, expert radiologist at Seattle Radiology, discusses difficulties in characterizing ambiguous imaging findings and the potential risks associated with radiation from medical imaging.

This interview by medical oncologist Dr. Jack West of Dr. David Djang, nuclear medicine expert in Seattle, covers the general principles and clinical utility of PET scans in lung cancer and other aspects of oncology.